US Stocks
/
Mirum Pharmaceuticals, Inc. Share Price
Mirum Pharmaceuticals, Inc. Share Price

Mirum Pharmaceuticals, Inc. Share Price

NASDAQ: MIRM | Mid Cap
$86.02
+$4.67 (5.74%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Mirum Pharmaceuticals, Inc. Stock Performance

Open
$81.35
Prev. Close
$81.35
Circuit Range
N/A
Day Range
$81.35 - $87.77
Year Range
$63.34 - $129.78
Volume
1,03,511
Average Traded
$86.26

Mirum Pharmaceuticals, Inc. Share Price Today

As of 10 October 2026, Mirum Pharmaceuticals, Inc.'s share price is $86.02. The stock opened at $81.35, compared to its previous close of $81.35. During today's trading session, Mirum Pharmaceuticals, Inc.'s share price traded between $81.35 and $87.77, with an average price of $84.56. Over the past 52 weeks, the stock has recorded a high of $129.78 and a low of $63.34. In terms of performance, Mirum Pharmaceuticals, Inc.'s share price has declined by 11.66% over the last six months and is up 18.39% on a year-on-year basis.

Mirum Pharmaceuticals, Inc. Share Price Chart

$81.35$87.77
L
Show Current Price
H

Mirum Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.32B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-13.25
Revenue (TTM)
$521.31B
Return On Equity (TTM)
8253.76%
Profit Margin
-4.48%
Debt to Equity
-71.97
Quarterly Earnings Growth YoY
-2410.31%

Mirum Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$133.01$148.93$159.88$176.24
Net Profit$2.91-$5.73-$790.16-$67.23
Net Profit Margin2.19%-3.85%-494.22%-38.15%
Income ChangeN/A-296.91%-13689.88%91.49%

Mirum Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$77.06$186.37$336.89$521.31
Net Profit-$135.67-$163.42-$87.94-$23.36
Net Profit Margin-176.06%-87.69%-26.10%-4.48%
Income ChangeN/A-20.45%46.19%73.44%

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Mirum Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$85.22
$85.95
+0.56%
Sep 2026
$98.00
$85.47
-14.27%
Aug 2026
$103.91
$99.70
-5.77%
Jul 2026
$118.68
$105.81
-9.53%
Jun 2026
$99.48
$116.95
+15.18%
May 2026
$96.34
$101.54
+4.28%
Apr 2026
$94.44
$97.37
+5.38%
Mar 2026
$89.20
$92.40
+0.15%
Feb 2026
$102.45
$92.27
-10.64%
Jan 2026
$78.74
$103.25
+30.79%
Dec 2025
$73.15
$78.95
+8.14%
Nov 2025
$71.77
$73.01
+0.48%

MIRM Share Price FAQs

What is Mirum Pharmaceuticals, Inc. share price today?

chevron-up
Mirum Pharmaceuticals, Inc. share price today is $86.02 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Mirum Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Mirum Pharmaceuticals, Inc. stock is $129.78, while the 52 week low is $63.34 as of 10 Oct '26.

What is MIRM's market capitalisation today?

chevron-up
MIRM market capitalisation is $4.32B as of October 10, 2026, at 11:10 am IST.

What is MIRM's net income for the last quarter?

chevron-up
MIRM's net income for the last quarter is -67.23B USD.

What is the 5 year returns of MIRM?

chevron-up
The 5 year returns of MIRM is 441.69% as on 10 Oct '26.

What is the high & low stock price of MIRM today?

chevron-up
MIRM stock price hit a high of $87.77 and low of $81.35 as of 10 Oct '26.

Can I buy MIRM shares in India?

chevron-up
Yes. You can buy MIRM in India by opening an international trading account.